Previous 10 | Next 10 |
DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective date of its ratio change of its American depositary shares (“ADSs”) from one (1) ADS representing four (4) Class A ...
2024-02-13 09:45:07 ET More on Trinity Biotech Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript) Financial information for Trinity Biotech Read the full article on Seeking Alpha For furthe...
DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs”) representing its Class A ordinary shares from one (1) ADS representing fou...
2024-02-11 01:25:00 ET Summary I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China for $80 M. Anbogen Therapeutics raised $12.5M in a Series A funding round. to advance its two lead drug candidates. Bayer signed a non-binding Letter of Intent to m...
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied for a Proprietary Laboratory Analyses (PLA) code for its Early Sjögrens Syndrome T...
A look at the top 10 most actives in the United States Connexa Sports Technologies Inc. (CNXA) rose 101.2% to $0.4 on volume of 236,162,112 shares PROSHARES TRUST (SQQQ) rose 5.9% to $12.78 on volume of 177,226,563 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 4.5% to $5....
2024-01-31 17:14:07 ET Trinity Biotech plc (TRIB) M&A and Q3 2023 Results Conference Call January 31, 2024 08:30 AM ET Company Participants Eric Ribner - Managing Director, LifeSci Advisors John Gillard - Chief Executive Officer Des Fitzgerald - Chief Financi...
2024-01-31 08:03:11 ET DENVER, Colo., Jan. 31, 2023 ( www.247marketnews.com )- Trinity Biotech plc (NASDAQ: TRIB) announced, this morning, its results for the quarter ended September 30, 2023, including business updates. Additionally, it published two press releases. Trinity Biotech...
2024-01-31 07:36:08 ET More on Trinity Biotech Financial information for Trinity Biotech Read the full article on Seeking Alpha For further details see: Trinity Biotech partners with Bayer to launch CGM device in China and India
2024-01-31 07:28:19 ET More on Trinity Biotech Financial information for Trinity Biotech Read the full article on Seeking Alpha For further details see: Trinity Biotech reports Q3 results
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the launch of its continuous glucose monitoring (“CGM”...